42 /100
MEDIUM RISK
Score updated Apr 13, 2026

GDTC

CytoMed Therapeutics Limited — Stock Dilution Tracker

Track GDTC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track GDTC — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
20
💰 Cash Runway
65
📊 Float Risk
65
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
24%
🔄 Reverse Split 40%
• 50-day avg $1.03 approaching $1 threshold
• 9 months cash with weak price
💰 Capital Raise 15%
• Under 12 months cash (9mo)
🔔 Track GDTC — Get forecast alerts →
💹 Market Data
Market Cap$11.83M
Shares Outstanding11.83M
Float3.97M
Cash$1.64M
Debt$378.4K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 67.4% shares (2026Q1 vs prior)
2 institutional holders · 5.9K shares
#1 Wealthspire Advisors, LLC 4.8K shares
#2 UBS Group AG 1.1K shares
📉 Short Interest
Short Interest82.7K
Days to Cover10.0
% of Float2.1%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Sep 30, 2025
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track GDTC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GDTC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required